rs146176992

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBS1BS2

The NM_012448.4(STAT5B):​c.247C>T​(p.Leu83Leu) variant causes a synonymous change. The variant allele was found at a frequency of 0.00536 in 1,613,614 control chromosomes in the GnomAD database, including 25 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0038 ( 1 hom., cov: 31)
Exomes 𝑓: 0.0055 ( 24 hom. )

Consequence

STAT5B
NM_012448.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 5.28

Publications

1 publications found
Variant links:
Genes affected
STAT5B (HGNC:11367): (signal transducer and activator of transcription 5B) The protein encoded by this gene is a member of the STAT family of transcription factors. In response to cytokines and growth factors, STAT family members are phosphorylated by the receptor associated kinases, and then form homo- or heterodimers that translocate to the cell nucleus where they act as transcription activators. This protein mediates the signal transduction triggered by various cell ligands, such as IL2, IL4, CSF1, and different growth hormones. It has been shown to be involved in diverse biological processes, such as TCR signaling, apoptosis, adult mammary gland development, and sexual dimorphism of liver gene expression. This gene was found to fuse to retinoic acid receptor-alpha (RARA) gene in a small subset of acute promyelocytic leukemias (APLL). The dysregulation of the signaling pathways mediated by this protein may be the cause of the APLL. [provided by RefSeq, Jul 2008]
STAT5B Gene-Disease associations (from GenCC):
  • growth hormone insensitivity syndrome with immune dysregulation
    Inheritance: SD Classification: DEFINITIVE Submitted by: Illumina
  • growth hormone insensitivity syndrome with immune dysregulation 2, autosomal dominant
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • growth hormone insensitivity with immune dysregulation 1, autosomal recessive
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • growth hormone insensitivity syndrome
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.34).
BP6
Variant 17-42227567-G-A is Benign according to our data. Variant chr17-42227567-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 282341.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00377 (573/152158) while in subpopulation SAS AF = 0.00664 (32/4820). AF 95% confidence interval is 0.00521. There are 1 homozygotes in GnomAd4. There are 260 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 24 AR,SD,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_012448.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
STAT5B
NM_012448.4
MANE Select
c.247C>Tp.Leu83Leu
synonymous
Exon 3 of 19NP_036580.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
STAT5B
ENST00000293328.8
TSL:1 MANE Select
c.247C>Tp.Leu83Leu
synonymous
Exon 3 of 19ENSP00000293328.3
STAT5B
ENST00000468312.1
TSL:1
n.416C>T
non_coding_transcript_exon
Exon 3 of 9
STAT5B
ENST00000415845.2
TSL:4
c.247C>Tp.Leu83Leu
synonymous
Exon 3 of 19ENSP00000398379.2

Frequencies

GnomAD3 genomes
AF:
0.00376
AC:
572
AN:
152038
Hom.:
1
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000894
Gnomad AMI
AF:
0.00219
Gnomad AMR
AF:
0.00203
Gnomad ASJ
AF:
0.0138
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00643
Gnomad FIN
AF:
0.00245
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00568
Gnomad OTH
AF:
0.00526
GnomAD2 exomes
AF:
0.00493
AC:
1239
AN:
251106
AF XY:
0.00516
show subpopulations
Gnomad AFR exome
AF:
0.000862
Gnomad AMR exome
AF:
0.00228
Gnomad ASJ exome
AF:
0.0130
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00333
Gnomad NFE exome
AF:
0.00631
Gnomad OTH exome
AF:
0.00848
GnomAD4 exome
AF:
0.00552
AC:
8072
AN:
1461456
Hom.:
24
Cov.:
31
AF XY:
0.00569
AC XY:
4135
AN XY:
727038
show subpopulations
African (AFR)
AF:
0.000777
AC:
26
AN:
33466
American (AMR)
AF:
0.00295
AC:
132
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.0130
AC:
341
AN:
26132
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39696
South Asian (SAS)
AF:
0.00668
AC:
576
AN:
86238
European-Finnish (FIN)
AF:
0.00434
AC:
232
AN:
53418
Middle Eastern (MID)
AF:
0.00754
AC:
42
AN:
5570
European-Non Finnish (NFE)
AF:
0.00573
AC:
6368
AN:
1111872
Other (OTH)
AF:
0.00587
AC:
354
AN:
60348
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.446
Heterozygous variant carriers
0
500
1000
1499
1999
2499
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
246
492
738
984
1230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00377
AC:
573
AN:
152158
Hom.:
1
Cov.:
31
AF XY:
0.00350
AC XY:
260
AN XY:
74382
show subpopulations
African (AFR)
AF:
0.000891
AC:
37
AN:
41524
American (AMR)
AF:
0.00203
AC:
31
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.0138
AC:
48
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5168
South Asian (SAS)
AF:
0.00664
AC:
32
AN:
4820
European-Finnish (FIN)
AF:
0.00245
AC:
26
AN:
10598
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00568
AC:
386
AN:
67992
Other (OTH)
AF:
0.00521
AC:
11
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
27
55
82
110
137
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00511
Hom.:
2
Bravo
AF:
0.00379
EpiCase
AF:
0.00671
EpiControl
AF:
0.00640

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Aug 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

STAT5B: BP4, BS2

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

not specified Benign:1
Aug 04, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Growth hormone insensitivity with immune dysregulation 1, autosomal recessive Benign:1
Feb 01, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.34
CADD
Benign
13
DANN
Benign
0.76
PhyloP100
5.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=83/17
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.19
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs146176992; hg19: chr17-40379585; COSMIC: COSV99510479; API